Led · Series B · Jan 2024

Shanghai Quanjing Medical Imaging Technology Co., Ltd. is described in the articles as China’s largest independent third‑party medical imaging center enterprise. The company is focused on medical imaging centers and related diagnostic imaging operations. Quanjing recently completed a Series B equity financing of more than RMB 600 million. The financing round was jointly led by Cathay Capital (中法凯辉基金), Yuanxing Capital (源星资本) and Yikai Future Industry Fund (易凯未来产业基金). Follow-on participants included TEDA Group (泰达集团), Su Min Tou Junxin Capital (苏民投君信资本) and existing investor Haida Venture Capital (海达创投). Yikai Capital served as the exclusive financial adviser to the transaction.

Led · Series C · Sep 2020

Suzhou Therypharm Pharmaceutical Co., Ltd is a pharmaceutical company identified with Suzhou in its name. The company completed a Series C financing of 250 million yuan (about $37 million). The Series C was co‑led by SND Ventures Group and CEC Capital. The article names only those two co‑lead investors and does not list additional participants. No operating metrics, product details, valuation, or use of proceeds were reported in the article.

Participated · Series B · May 2020

Sanbo Brain is a specialty medical group focused on neurological care, integrating clinical services, teaching and research across its hospitals. Founded in 2004, the group operates seven large hospitals (one under construction) covering Beijing, Chongqing, Hunan, Fujian, Henan and Yunnan. Its flagship, Capital Medical University Sanbo Brain Hospital, is repeatedly ranked among the top neurosurgery centers in Beijing. The group centers its clinical strength on a roster of senior neurology and neurosurgery experts and has built systematic talent training and research capabilities. Sanbo says it will increase investment in research translation, talent reserves and medical hardware while rolling out a regional network to achieve scaled growth. Financially, Sanbo Brain recently completed a B‑round equity financing of over RMB 800 million, which the company says will support nationwide expansion and consolidation of its brand and services.

Participated · Series D · Nov 2018

Ucommune operates a network of more than 200 co-working spaces across 37 cities, including locations in Singapore, New York, Taipei and Hong Kong, serving clients such as ByteDance, Ofo, Mobike and Kuaishou. The company’s core product is flexible workspace and related workplace services, and it has pursued aggressive consolidation, acquiring seven companies this year including Fountown (27 spaces) and several co-working brands plus an interior design firm and a workplace collaboration startup. Ucommune says it currently has about 100,000 workstations and plans to double capacity to 200,000 over the next three years while expanding to 350 cities across 40 countries. Financially, the company closed a $200M Series D that values it at $3 billion and brings total capital raised to around $650 million to date, according to Crunchbase. Ucommune was founded in 2015 and positions itself as WeWork’s main rival in China, where WeWork China has roughly 40 locations. The company is also moving into new international markets, with plans to open an inaugural Hong Kong space in December and a second in early next year. Ucommune operates flexible co-working and office spaces, claiming to manage 160 locations in over 35 cities. The company, formerly known as UrWork, competes directly with WeWork China and maintains a presence outside Asia in New York, London, Hong Kong and Taiwan. Ucommune announced a $43.5 million Series C at a $1.8 billion post-money valuation. The round was led by real estate-focused Prosperity Holdings and RK Properties, both described as strategic investors. Prosperity will help the company expand its presence in Southeast Asia (Ucommune already has operations in Singapore and an investment in Indonesia), while RK Properties will assist in upgrading existing office spaces, possibly akin to WeWork’s ‘Powered By We’ program. To date Ucommune has raised roughly $450 million and this year has completed four acquisitions, including Workingdom for around $45 million. UrWork is a Beijing-based co-working space provider founded in 2015 by Dr. Mao Daqing. The company offers long-term leasing, hot desk and corporate-customization solutions as well as professional services for SMEs. It currently covers over 100 locations across more than 30 cities worldwide, including Singapore, New York, Los Angeles, San Francisco and London. UrWork services over 3,000 enterprises and 40,000 individual members in total. The company completed a $45M Series C that valued it at $1.3 billion and plans to use the funds to drive further global expansion, community service and technology upgrading. The latest round was led by Qianhai Wutong Mergers and Acquisitions Funds with participation from CK Home — Key Investment Group and Context Lab. UrWork is a Beijing-based co-working leader that provides on-demand, short-term leasing and customized space solutions to startups, SMEs and corporate tenants. The company aggregates over 1,000 professional business service suppliers and serves over 40,000 individual members and more than 3,000 enterprises, including corporate members such as ofo bike, BlueGogo, Mobike, Amazon China, Jin Ri Tou Tiao, Netease and JD Logistics. UrWork offers an in-house Express Financing program, a series of acceleration programs, and the Link China Program to help foreign startups enter the Chinese market. As of August 2017 it operated 88 locations in over 22 cities and plans to open another 160 locations across 32 cities worldwide over the next three years. The expansion target covers a total area of over 7M sq.ft. The company raised a US$178M pre-C round resulting in a post-C valuation of US$1.5 billion and intends to use the funds for further global expansion and technology upgrading; it is led by founder and CEO Dr. Mao Daqing. URWork operates shared office space and offers complementary value-added services such as financial services, human resources, and healthcare to its community. The company reports annual revenue of around RMB 400 million ($58.5 million), with roughly 75% from core office space rentals and 25% from value-added offerings. URWork says it serves about 2,400 companies across 24 cities in China and has begun overseas expansion to Singapore, London, Taiwan and New York City. Since launching in April 2015 the company has completed six funding rounds and one merger. URWork aims to deepen and broaden its service portfolio to unlock additional monetization around its community. The partnership with Aikang is intended to bring traditional-sector resources to build a more specialized, service-oriented co-working experience beginning in the first half of 2018.

Participated · Series B · Dec 2012

Enevate develops and licenses advanced silicon-dominant Li-ion battery technology that delivers extreme fast charging and high energy density for electric vehicles and other markets. The company markets a technology it says enables five-minute extreme fast charging, low-temperature operation, lower cost and safety advantages versus conventional batteries, and supports pouch and cylindrical cell formats. Its business model focuses on technology transfer and intellectual property licensing to automotive OEMs and EV battery manufacturers, enabling use of existing manufacturing infrastructure with minimal additional investment. Enevate holds a portfolio of more than 350 patents issued and pending and states its patents cover jurisdictions representing over 95% of EV sales worldwide, claiming the largest patent portfolio among silicon Li-ion startups. The Irvine, California–based company works with multiple OEMs and battery manufacturers and plans to expand a pre-production line to guide customers toward larger-scale manufacturing. It intends to use new funding to hire additional scientists and engineers and to scale commercialization. With the latest round, Enevate has raised $191 million to date. Enevate develops and licenses silicon-dominant Li-ion battery technology (HD-Energy®) that delivers extreme-fast charging—about five-minute charge times—alongside high energy density, strong low-temperature performance, lower cost, and safety advantages. The company licenses its HD-Energy technology to battery and EV automotive manufacturers and suppliers worldwide to accelerate production volume and adoption. Enevate emphasizes low-temperature operation for cold climates, long driving range, and rapid charging as core product benefits. Leadership projects a future where EV drivers can use drive-thru style charging stations and be back on the road in roughly five minutes. Enevate is headquartered in Irvine, Calif., and lists a group of strategic investors backing its technology. Bangchak, through its Bangchak Initiative and Innovation Center (BiiC), has recently invested in the company; the investment amount was not disclosed. Enevate Corporation, headquartered in California, develops and licenses silicon-dominant lithium-ion battery technology aimed at accelerating EV adoption. Its HD-Energy technology enables extreme fast charging, allowing cells to reach 75% capacity in five minutes while delivering higher energy density than many current long-range EV batteries. The technology also supports safe charging and discharging down to -40°C and captures more energy during regenerative braking, improving range in cold climates. Enevate offers a complete HD-Energy technology and licensing package to enable global EV automakers and battery manufacturers to reach production volumes and adopt next-generation features. The company announced that LG Chem participated in its recent funding, and its investor roster includes Mission Ventures, Draper Fisher Jurvetson, Tsing Capital, Samsung, Lenovo, and others. Enevate plans to commercialize its technology through strategic partnerships with manufacturers and licensors to accelerate deployment worldwide. Enevate develops advanced Li‑ion batteries built on its HD‑Energy Technology, which uses silicon‑dominant composite anodes and novel cell designs. The company says this approach increases volumetric and gravimetric energy density by 25–50% versus conventional graphite anode cells. Its batteries enable thinner, lighter form factors for smartphones, tablets, ultra‑thin notebook PCs and drones with longer runtimes. Enevate characterizes the technology as representing over a decade of advancement relative to current Li‑ion improvement rates. The company is headquartered in Irvine, California, and lists investors including Mission Ventures, Draper Fisher Jurvetson, Tsing Capital, Infinite Potential Technologies, Presidio Ventures and CEC Capital. Management plans to use new funding to move products developed for its first strategic investors and customers into high‑volume mass production and to expand into applications such as drones. Enevate Corporation is an Irvine, California–based developer of advanced rechargeable lithium‑ion (Li‑ion) batteries. The company focuses on next‑generation Li‑ion batteries for smartphones, tablets, and ultra‑thin notebook PCs. Its HD‑Energy Technology utilizes silicon composite anodes in rechargeable Li‑ion polymer batteries to increase energy density over conventional graphite anode cells. Led by CEO Brian Wong, Enevate completed a $24M Series B financing. Backers include new investors CEC Capital, Tsing Capital, Presidio Ventures (a Sumitomo Corporation company), other strategic investors, and existing investors Mission Ventures and Draper Fisher Jurvetson. The company intends to use the funding to bring its first products to market.